The world drifting to other crises such as COVID-19, Ebola, Cholera, there came an almost unknown rival-virus quietly spreading in parts of West Africa. An acute viral hemorrhagic disease, first detected in 1969 in Nigeria, it is still a recurrent health emergency in countries such as Nigeria, Liberia, Sierra Leone, and Guinea. The Lassa virus is through food or household items contaminated with putrefied excretion from infected Mastomys rodents, which are the greatest hazard in rural and under-resourced areas of certain West African countries.
The very beginning of 2023 saw one of the biggest outbreaks in recent Nigerian history. Over 1,000 cases were confirmed, and hundreds of deaths were recorded, mostly from states characterized by poor sanitation, overcrowded hospitals, and late intervention. Lassa Fever, with its atrocious mortality, especially amongst treated patients, has been unfairly neglected or has no effective vaccines and mass awareness.
The health-care systems in the region go against containing the spread of the malignancy because of unastern diagnostic tools, poor surveillance, and fear of infection by the very personnel who are deficient in personal protective equipment. It is basically temperature in the initial month combined with general weakness, headache, and malaise. Then sore throat, muscle pain, chest pain, nausea, vomiting, diarrhea, cough, and abdominal pain can develop. In really bad scenarios, bouts of facial swelling with collection of fluid into the lung cavity are expected, and bleeding may also occur from the mouth, some parts of the nose, the vagina, or the gastrointestinal tract, along with unnecessarily low blood pressure in the body. During the further stages, shock, seizures, tremor, disorientation, and coma are also to be observed. In addition, symptoms similar to those found in Lassa fever also show up in malaria, typhoid fever, yellow fever, and Ebola, which causes misdiagnosis, a late period of isolation, and further proceed with the spread of the outbreak.
In Graver Concerned, attempts have been made by international organizations to produce a vaccine by WHO and the Coalition for Epidemic Preparedness Innovations (CEPI). Early-stage trials are currently ongoing; however, the experts assert, fearing that unless the disease gets serious funding, stand-alone surveillance, and reproached every year. Community outreach capabilities are yet to be set up to educate many unaware people in high-risk areas on how this disease spreads. Hence, making public education campaigns on food safety, sanitation, and rodent control much imperative.
The indelible impression of Lassa fever serves as a reminder of ailings, not given global headlines but which do much damage to the local populace. Better public health infrastructure, investment in vaccine research, and emphasis on regional disease surveillance should thwart this from ever occurring again. Lassa fever still manages to be the silent killer-deadly, persistent, and often overlooked.
Leave a Reply